viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
uurimisrühmad - Charles University in Prague, Department of Pharmaceutical technology
Charles University in Prague, Department of Pharmaceutical technology
Hradec Kralove
zdenka.sklubalova@faf.cuni.cz
Viited
(3)
1
Furosemide ethanol-free oral solutions for paediatric use : formulation, HPLC method and stability study.
Zahalka L, Klovrzova S, Matysova L, Sklubalova Z, Solich P. (sklubalova@faf.cuni.cz)
EJHP -
2018
- ;25,3:144-149
2
Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P. (zdenka.sklubalova@faf.cuni.cz)
EJHP -
2016
- ;23:33-37
3
A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor.
Sestak V, Roh J, Klepalova L, Kovarikova P. (petra.kovarikova@faf.cuni.cz)
J Pharm Biomed Anal -
2016
- ;124:365-373
molekulid uuritud
(3)
Carfilzomib
Furosemide
Sotalol hydrochloride
Mentions Légales
